How BPC-157 works

BPC-157 is known as a “stable gastric pentadecapeptide” primarily because it is stable in human gastric juice, can cause an anabolic healing effect in both the upper and lower GI tract, has an antiulcer effect, and produces a therapeutic effect on inflammatory bowel disease (IBD)—all surprisingly free of side effects.

BPC-157 also accelerates wound healing, and—via interaction with the Nitric Oxide (NO) system—causes protection of endothelial tissue and an “angiogenic” (blood vessel building) wound-healing effect. This occurs even in severely impaired conditions, such as in advanced and poorly controlled irritable bowel disease, in which it stimulates expression of genes responsible for cytokine and growth factor generation and also extracellular matrix (collagen) formation, along with intestinal anastomosis healing, reversal of short bowel syndrome and fistula healing—all of which can extremely frustrating issues in people who have gut pain, constipation, diarrhea, and bowel inflammation.